DUMONT & BLAKE INVESTMENT ADVISORS LLC - Blueprint Medicines Corp ownership

Back to all holdings Add to watchlist

Blueprint Medicines Corp's ticker is and the CUSIP is 09627Y108. A total of 1 filers reported holding Blueprint Medicines Corp in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Links
Filings
Quarter-by-quarter ownership
DUMONT & BLAKE INVESTMENT ADVISORS LLC ownership history of Blueprint Medicines Corp
ValueSharesWeighting
Q4 2017$302,000
+13.1%
4,000
-55.6%
0.12%
-6.1%
Q3 2016$267,000–9,000–0.13%–
 Download
Other shareholders
Blueprint Medicines Corp shareholders Q4 2017
NameSharesValueWeighting ↓
DUMONT & BLAKE INVESTMENT ADVISORS LLC 4,000$302,0000.12%
View complete list of Blueprint Medicines Corp shareholders